Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 25,885 | 21,030 | 2,399 | 7,333 | 11,234 |
| Operating Income | -25,885 | -21,030 | -2,399 | -7,333 | -11,234 |
| Interest Expense | 0 | 1,073 | 0 | 0 | 0 |
| Other Income | 1,278 | 313 | 55 | 110 | 1,410 |
| Pre-tax Income | -24,607 | -21,790 | -2,344 | -7,223 | -9,824 |
| Net Income Continuous | -24,607 | -21,790 | -2,344 | -7,223 | -9,824 |
| Net Income | $-24,607 | $-21,790 | $-2,344 | $-7,223 | $-9,824 |
| EPS Basic Total Ops | -1.27 | -4.93 | -4.00 | -11.00 | -15.00 |
| EPS Basic Continuous Ops | -1.49 | -5.65 | -3.63 | -11.20 | -15.24 |
| EPS Diluted Total Ops | -1.27 | -4.93 | -4.00 | -11.00 | -15.00 |
| EPS Diluted Continuous Ops | -1.49 | -5.65 | -3.63 | -11.20 | -15.24 |
| EPS Diluted Before Non-Recurring Items | -1.27 | -4.93 | -4.00 | -11.00 | -15.00 |
| EBITDA(a) | $-25,857 | $-21,030 | $-2,399 | $-7,333 | $-11,226 |